Women urge FDA to pull contraceptive device linked to pain
WASHINGTON - Women who received a metallic birth control implant are urging health regulators to pull the device from the market, citing problems like severe pain, bleeding and weight gain.
The Essure implant has been sold for more than a decade and is frequently pitched to women as the only non-surgical option for permanent birth control. The German manufacturer Bayer estimates 750,000 women have received the device since 2002.
But since 2013, the Food and Drug Administration has received thousands of complaints about the device from women and doctors. While the product's label warns about pelvic pain and bleeding immediately after the procedure, many women said these problems persisted and were so severe they required surgery to remove the device.
The FDA convened a panel of experts Thursday to review the device's safety.
Desktop NewsClick to open Continuous News in a sidebar that updates in real-time.
Livingston residents are still experiencing flooding issues
A federally-backed mass vaccination site opened up at Bon Carre Business Center...
Residents along the Amite River have been dealing with flooded roads since...
Local restaurants struggling to hire employees as business increases
COAST GUARD: Two more unresponsive crew members recovered from capsized lift boat...
Legendary Parkview coach Kenny Guillot passes away at 76
Southern Wins Third Straight Bayou Classic
White squad edges Purple in LSU Spring game
'We have a plan': Coach O quiet on how Title IX scandal...
Southeastern regains sole possession of first place in Southland standings with win...